206. Deputy Stephen S. Donnelly asked the Minister for Health if a detailed analysis of the decision not to make Spinraza available to persons here will be provided including but not limited to the final agreed costs to the HSE and the final agreed costs in all other relevant jurisdictions; if the costs for Ireland are broadly comparable to all other jurisdictions in which Spinraza is being made available; the rationale for it not being made available here; and if he will make a statement on the matter. [11180/19]

Summary

206. Deputy Stephen S. Donnelly asked the Minister for Health if a detailed analysis of the decision not to make Spinraza available to persons here will be provided including but not limited to the final agreed costs to the HSE and the final agreed costs in all other relevant jurisdictions; if the costs for Ireland are broadly comparable to all other jurisdictions in which Spinraza is being made available; the rationale for it not being made available here; and if he will make a statement on the matter. [11180/19]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Availability

  xml · EN · 6 March 2019

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.